United States · Bill · S
S. 440 (116th)
PACED Act
Introduced
12 February 2019
Last action
—
Status
Placed on Senate Legislative Calendar under General Orders. Calendar No. 129.
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Preserving Access to Cost Effective Drugs Act or the PACED Act This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission. Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
6 official files
Reported to Senate (text)
Reported to Senate (text)
Reported to Senate · EN · 28 June 2019
Reported to Senate (PDF)
Reported to Senate · EN · 28 June 2019
Reported to Senate
summary · EN · 28 June 2019
Introduced in Senate (text)
Introduced in Senate · EN · 12 February 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 12 February 2019
Introduced in Senate
summary · EN · 12 February 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/440
- Open data entity: https://api.congress.gov/v3/bill/116/s/440